What is BD?
BD is recognized as one of the world's largest medical technology firms, dedicated to advancing global health. The company's mission is to improve medical discovery, diagnostics, and the delivery of care. BD supports healthcare professionals by developing innovative technologies, services, and solutions designed to enhance both clinical therapy for patients and the efficiency of clinical processes for healthcare providers. Its operations span across critical areas of healthcare, aiming to drive progress and improve outcomes worldwide.
How much funding has BD raised?
BD has raised a total of $71M across 3 funding rounds:
Stock Offering
$12M
Grant
$24M
Other Financing Round
$35M
Stock Issuance/Offering (1962): $12M, investors not publicly disclosed
Grant (2020): $24M led by U.S. Department of Defense and U.S. Department of Health and Human Services
Other Financing Round (2025): $35M, investors not publicly disclosed
Key Investors in BD
U.S. Department of Defense
The U.S. Department of Defense is a federal entity focused on national security and military operations, likely investing in technologies that support defense and advanced healthcare solutions for service members.
What's next for BD?
The substantial enterprise-level funding, including the recent strategic investment, indicates BD is likely in a scaling or expansion phase, focusing on enhancing its technological capabilities and market reach. This capital infusion is expected to fuel further innovation in its core areas of medical discovery, diagnostics, and care delivery. BD's strategic focus on supporting frontline healthcare heroes suggests a commitment to developing solutions that address pressing global health challenges and improve healthcare system efficiencies. The company's trajectory points towards continued leadership and impact within the medical technology landscape.
See full BD company page
